IP Group PLC — Director's Dealing 2022

Sep 20, 2022

National Storage Mechanism | Additional information

RNS Number : 0535A

IP Group PLC

20 September 2022

FOR RELEASE ON	# 20 September 2022

IP Group plc - Director/PDMR Shareholding

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which develops world-changing science and technology businesses across life sciences, technology and cleantech, announces that, further to the announcements dated 03 August 2022, 18 August 2022, 13 September 2022 and 14 September 2022 in connection with the Interim Scrip Dividend, a combined total of 3,408 new ordinary shares of 2p each ("Shares") in aggregate have been allotted to one of the Group's executive directors and four of its persons discharging managerial responsibilities ("PDMRs"), following their respective elections to take up the Interim Scrip Dividend in relation to some or all of their current shareholdings, as further detailed below. 

Shares in issue

The Group currently has 1,063,188,005 Shares in issue and 28,607,622 Shares held in Treasury.

The following information is being disclosed pursuant to the requirements of MAR.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

Scrip Election

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name(s)

Greg Smith

Heejae Chae

Christopher Glasson

Angela Leach

Lisa Patel

2

Reason for the notification

a)

Position/status

Executive Director          Chief Executive Officer

PDMR                             Non-Executive Director          PDMR                             Finance Director

PDMR                             Group General Counsel

PDMR                             Partner, Life Sciences

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

Legal Entity Identifier

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

ISIN: GB00B128J450

b)

Nature of the transaction

Election of Scrip Dividend

c)

Currency

GBP

d)

Price(s) and volume(s)

Name(s)	Price(s)	Volume(s)
Greg Smith	80.5p	1,493
Heejae Chae	80.5p	99
Chris Glasson	80.5p	68
Angela Leach	80.5p	1,684
Lisa Patel	80.5p	64

e)

Aggregated information

-Aggregated volume

- Price

- Aggregated total

Aggregated Number of Shares: 3,408

Price: 80.5p

Aggregated Total: £2,743.44

f)

Date of the transaction

20 September 2022

g)

Place of the transaction

London Stock Exchange, Main Market

For more information, please contact:

IP Group plc	www.ipgroupplc.com
David Baynes, Chief Financial and Operating Officer Liz Vaughan-Adams, Communications	+44 (0) 20 7444 0050 +44 (0) 20 7444 0062/+44 (0) 7967 312125

Notes for editors

About IP Group

IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech (through Kiko Ventures). The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

For more information, please visit our website at www.ipgroupplc.com.

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHPPURUBUPPGMU